StonvexLoading…
StonvexCore line items from BATL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $164.96M | $193.22M | $218.50M | $357.40M |
Operating Income | $-6.64M | $-11.74M | $17.58M | $152.14M |
Net Income | $11.88M | $-31.88M | $-3.05M | $18.54M |
EPS (Diluted) | $-2.24 | $-3.90 | $-0.92 | $1.12 |
Total Assets | $460.68M | $431.05M | $485.34M | $485.36M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $27.96M | $19.71M | $57.53M | $32.73M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 16.46M | 16.46M | 16.46M | 16.34M |